Anti-AKR1C3+AKR1C4 antibody [EPR16726]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal AKR1C3 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 10 publications.
View Alternative Names
DDH1, HSD17B5, KIAA0119, PGFS, AKR1C3, Aldo-keto reductase family 1 member C3, 17-beta-hydroxysteroid dehydrogenase type 5, 3-alpha-hydroxysteroid dehydrogenase type 2, Chlordecone reductase homolog HAKRb, Dihydrodiol dehydrogenase 3, Dihydrodiol dehydrogenase type I, HA1753, Prostaglandin F synthase, Testosterone 17-beta-dehydrogenase 5, 17-beta-HSD 5, 3-alpha-HSD type 2, DD-3, DD3
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized A549 (Human lung carcinoma cell line) cells labeling AKR1C3 with ab209899 at 1/100 dilution followed by Goat anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing cytoplasmic staining on A549 cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin antibody - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (Alexa Fluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows : -
-ve control 1 : ab209899 at 1/100 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed A549 (Human lung carcinoma cell line) cells labeling AKR1C3with ab209899 at 1/70 dilution (red) compared with a Rabbit IgG,monoclonal- Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti Rabbit IgG (Alexa Fluor® 488) at 1/500 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HepG2 (Human liver hepatocellular carcinoma cell line) cells labeling AKR1C3 with ab209899 at 1/100 dilution followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing cytoplasmic staining on HepG2 cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin antibody - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows : -
-ve control 1 : ab209899 at 1/100 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
AKR1C3 was immunoprecipitated from 1mg of HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate with ab209899 at 1/30 dilution.
Western blot was performed from the immunoprecipitate using ab209899 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HepG2 whole cell lysate, 10μg (Input).
Lane 2 : ab209899 IP in HepG2 whole cell lysate.
Lane 3 : Rabbit IgG,monoclonal - Isotype Control (ab172730) instead of ab209899 in HepG2 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 second.
All lanes:
Immunoprecipitation - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899)
Predicted band size: 37 kDa
false
- WB
Supplier Data
Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899) at 1/2000 dilution
Lane 1:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate (control) at 10 µg
Lane 2:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg with AKR1C3 peptide on the membrane
Lane 3:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg with AKR1C4 peptide on the membrane
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 37 kDa
Observed band size: 37 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
Blocking and dilution buffer : 5% NFDM/TBST
Lanes 1 - 4:
Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899) at 1/1000 dilution
Lanes 1 - 4:
Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/akr1c3akr1c4-antibody-epr16726-bsa-and-azide-free-ab251511'>ab251511</a>) at 1/1000 dilution
Lane 1:
His-tagged human AKR1C1 recombinant protein, full-length
Lane 2:
His-tagged human AKR1C2 recombinant protein, full-length
Lane 3:
His-tagged human AKR1C3 recombinant protein, full-length
Lane 4:
His-tagged human AKR1C4 recombinant protein, full-length
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/20000 dilution
Observed band size: 39 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1/3 : 2 seconds; Lane 2 : 30 seconds.
Lanes 1 - 2:
Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899) at 1/1000 dilution
Lane 3:
Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899) at 1/5000 dilution
Lane 1:
Human fetal kidney lysate at 20 µg
Lane 2:
MOLT-4 (Human lymphoblastic leukemia cell line) whole cell lysate at 20 µg
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 37 kDa,90 kDa
Observed band size: 37 kDa
false
Related conjugates and formulations (1)
-
Anti-AKR1C3+AKR1C4 antibody [EPR16726] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The proteins AKR1C3 and AKR1C4 have significant roles in steroid hormone metabolism. They do not form a part of any larger complex but act independently to catalyze the conversion of active androgens and estrogens. AKR1C3 for example converts androstenedione to testosterone and estrone to estradiol affecting steroid balance in tissues. Meanwhile AKR1C4 primarily catalyzes the reduction of bile acid intermediates assisting in maintaining liver health and function.
Pathways
AKR1C3 and AKR1C4 operate closely in metabolic pathways involving steroid metabolism and bile acid biosynthesis. In the steroid metabolism pathway they associate with other enzymes like 5α-reductase and CYP19A1 (aromatase) to regulate the conversion and amplification of steroid hormones. In bile acid biosynthesis AKR1C4 works conjointly with enzymes like CYP7A1 playing a significant role in processing cholesterol substrates into bile acids important for lipid digestion and absorption.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:111808 PubMed39995859
2025
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 14:7623-7644 PubMed39659569
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:3807-3825 PubMed37166429
2023
Applications
Unspecified application
Species
Unspecified reactive species
Endocrinology 164: PubMed36799021
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 21:55 PubMed36803994
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:849242 PubMed35646665
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:5809 PubMed35388063
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:823491 PubMed35359392
2022
Applications
Unspecified application
Species
Unspecified reactive species
Archives of toxicology 94:3059-3068 PubMed32588086
2020
Applications
Unspecified application
Species
Unspecified reactive species
Reproduction (Cambridge, England) 158:493-501 PubMed31671404
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com